University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 0S-11-5


Circulating Tumor Cell Collection from Cancer Patients.

Type: Specimen Study
Phase: Not Applicable
Status: Open to Accrual
Treatments: Other
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Amir Goldkorn, M.D.
Other Trial Staff:  Kristy Watkins, R.N., Ramona Lujan, R.N., Charlean Ketchens, R.N., Jiayi Jiang, D.M., Nancy Perez, R.N., Lagrimas Ilagan, D.M., Gina Tse, R.N., Xiomara Menendez, R.N., Noureddine Miloud, D.M., Jessica Levano, R.N., Honorina Enright, D.M., Pritesh Chaudhari, D.M., Catherine Ticong, R.N.

Staff may log in to see study documents.


You may participate in this study if:
 Requirement
1All cancer patients >18 years of age diagnosed with a solid tumor (i.e., non-leukemic) malignancy encountered at their regularly scheduled appointments will be eligible. These will include lymphomas and myelomas (only leukemias will be excluded).
2At the conclusion of their encounters with their oncology care provider, the patient will be informed briefly about the purpose of the study and asked if he/she would be willing to provide consent for the additional single-stick venipuncture to be done at the time of other laboratory blood draws.
3Patients will be told that their participation is completely voluntary, and that their decision will in no way impact their care at USC.
4Phycians or research coordinators will consent and register patients in café and will provide the registration confirmation and informed consent to the PI





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.